Myosin 1e promotes breast cancer malignancy by enhancing tumor cell proliferation and stimulating tumor cell de-differentiation
Metrics: PDF 1238 views | HTML 2283 views | ?
Jessica L. Ouderkirk-Pecone1, Gregory J. Goreczny1, Sharon E. Chase1, Arthur H. Tatum2, Christopher E. Turner1, Mira Krendel1
1Department of Cell and Developmental Biology, SUNY Upstate Medical University, Syracuse, NY 13210, USA
2Department of Pathology, SUNY Upstate Medical University, Syracuse, NY 13210, USA
Mira Krendel, email: email@example.com
Keywords: myosin, breast cancer, tumor promotion and progression, animal models of cancer, therapeutic targets
Received: May 05, 2015 Accepted: June 01, 2016 Published: June 17, 2016
Despite advancing therapies, thousands of women die every year of breast cancer. Myosins, actin-dependent molecular motors, are likely to contribute to tumor formation and metastasis via their effects on cell adhesion and migration and may provide promising new targets for cancer therapies. Using the MMTV-PyMT murine model of breast cancer, we identified Myosin 1e (MYO1E) as a novel tumor promoter. Tumor latency in mice lacking MYO1E was significantly increased, and tumors formed in the absence of MYO1E displayed unusual papillary morphology, with well-differentiated layers of epithelial cells covering fibrovascular cores, rather than solid sheets of tumor cells typically observed in this cancer model. These tumors were reminiscent of papillary breast cancer in humans that is typically non-invasive and often cured by tumor excision. MYO1E-null tumors exhibited decreased expression of the markers of cell proliferation, which was recapitulated in primary tumor cells derived from MYO1E-null mice. In agreement with our findings, meta-analysis of patient survival data indicated that MYO1E expression level was associated with reduced recurrence-free survival in basal-like breast cancer. Overall, our data suggests that MYO1E contributes to breast tumor malignancy and regulates the differentiation and proliferation state of breast tumor cells.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.